KRAS and familial pancreatic carcinoma: Of note, TXN is dysregulated in pancreatic cancer where it regulates KRAS signaling pathway (Schultz et al., 2017), indicating that it may represent a good strategy to induce ferroptosis in RAS-driven cancers.